James F III Oliviero
CIK 1434718 · CEO, President and Director · last filed 2025-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$940.6K
Companies
3
Total Filings
66
Lifetime Open-Market Net
-$15.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVCT | Director | 87,828 | $10.71 | $940.6K | $0 | 4 | 2025-06-12 |
| Checkpoint Therapeutics, Inc. (CKPT) Delisted | CEO, President and Director | 0 | $4.26 | $0 | -$4.34M | 22 | 2025-05-30 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Chief Financial Officer | 209,406 | — | — | -$10.69M | 39 | 2015-07-08 |
Recent Filings · Page 5 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-14 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −29,363 | -$244.9K | EDGAR |
| 2013-04-08 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −1,484 | -$10.3K | EDGAR |
| 2013-01-04 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Mixed | +22,661 | -$29.8K | EDGAR |
| 2012-10-05 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −4,973 | -$13.5K | EDGAR |
| 2012-07-06 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −4,559 | -$9.1K | EDGAR |
| 2012-05-22 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +400,000 | $0 | EDGAR |
| 2012-04-05 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −5,458 | -$8.7K | EDGAR |
| 2012-01-03 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Mixed | +20,810 | -$18.9K | EDGAR |
| 2011-10-05 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −6,105 | -$17.2K | EDGAR |
| 2011-07-07 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Sell (S) | −4,611 | -$22.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.